NDC 0169-7830

NOVOEIGHT

(antihemophilic Factor, Recombinant)

NOVOEIGHT is a Kit in the Plasma Derivative category. It is labeled and distributed by Novo Nordisk. The primary component is .

Product ID0169-7830_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884
NDC0169-7830
Product TypePlasma Derivative
Proprietary NameNOVOEIGHT
Generic Name(antihemophilic Factor, Recombinant)
Dosage FormKit
Marketing Start Date2015-04-01
Marketing CategoryBLA / BLA
Application NumberBLA125466
Labeler NameNovo Nordisk
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0169-7830-01

1 KIT in 1 KIT (0169-7830-01) * 4 mL in 1 VIAL, GLASS (0169-7831-11) * 4 mL in 1 SYRINGE, GLASS (0169-7008-98)
Marketing Start Date2015-04-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0169-7830-01 [00169783001]

NOVOEIGHT KIT
Marketing CategoryBLA
Application NumberBLA125466
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2015-04-01

Drug Details

NDC Crossover Matching brand name "NOVOEIGHT" or generic name "(antihemophilic Factor, Recombinant)"

NDCBrand NameGeneric Name
0169-7810NOVOEIGHT(antihemophilic factor, recombinant)
0169-7815NOVOEIGHT(antihemophilic factor, recombinant)
0169-7820NOVOEIGHT(antihemophilic factor, recombinant)
0169-7825NOVOEIGHT(antihemophilic factor, recombinant)
0169-7830NOVOEIGHT(antihemophilic factor, recombinant)
0169-7850NOVOEIGHT(antihemophilic factor, recombinant)

Trademark Results [NOVOEIGHT]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NOVOEIGHT
NOVOEIGHT
79062796 3728571 Live/Registered
Novo Nordisk Health Care AG
2008-10-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.